Elevation Oncology, Inc. Quarterly Debt-to-equity in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Elevation Oncology, Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q3 2024.
  • Elevation Oncology, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 49.2 %, a 34.9% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 49.2 -26.3 -34.9% Sep 30, 2024
Q2 2024 50.6 -26.3 -34.2% Jun 30, 2024
Q1 2024 54 -5.61 -9.41% Mar 31, 2024
Q4 2023 68.6 +34.1 +98.7% Dec 31, 2023
Q3 2023 75.4 +56.5 +298% Sep 30, 2023
Q2 2023 76.9 +67.8 +745% Jun 30, 2023
Q1 2023 59.6 +54 +965% Mar 31, 2023
Q4 2022 34.5 Dec 31, 2022
Q3 2022 19 Sep 30, 2022
Q2 2022 9.1 Jun 30, 2022
Q1 2022 5.59 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.